Viewing Study NCT03377556


Ignite Creation Date: 2025-12-24 @ 11:17 PM
Ignite Modification Date: 2026-01-02 @ 8:34 AM
Study NCT ID: NCT03377556
Status: COMPLETED
Last Update Posted: 2021-06-23
First Post: 2017-12-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Sponsor: SWOG Cancer Research Network
Organization: